About Dan

This author has not yet filled in any details.
So far Dan has created 13 blog entries.

Dr. Trevejo discusses the importance of diversity in clinical trials and the non-viral gene therapy we are developing against COVID-19

Watch as our CEO Dr. Trevejo discusses the importance of diversity in clinical trials and the non-viral gene therapy we are developing to treat infection with Coronavirus. Watch now on CityLine.

By |2020-03-26T11:22:04-04:00March 26th, 2020|Interview|0 Comments

Sorrento Therapeutics and SmartPharm Therapeutics Announce Intention to Collaborate to Develop Novel Gene-Encoded Antibody Vaccine Intended for COVID-19

For Immediate Release March 23, 2020     SORRENTO AND SMARTPHARM TO COLLABORATE TO DEVELOP NOVEL GENE-ENCODED ANTIBODY VACCINE INTENDED TO PROTECT AGAINST COVID-19 Collaboration to leverage synergies between Monoclonal Antibody and Non-Viral Gene Delivery Platforms SAN DIEGO and BOSTON, March 23, 2020 /GlobeNewswire/ -- In response to the government call for rapidly deployable countermeasures, [...]

By |2020-03-23T10:00:18-04:00March 23rd, 2020|Press Releases|0 Comments

SmartPharm Therapeutics Appoints John T. Potts, MD, DSc, to Board of Directors

CAMBRIDGE, Mass., Oct. 21, 2019 /PRNewswire/ -- SmartPharm Therapeutics, a preclinical-stage pharmaceutical company focused on developing next-generation, non-viral gene therapies for the treatment of rare diseases, today announced the appointment of John T. Potts, MD, DSc, to its Board of Directors. Dr. Potts' distinguished, five-decade career in healthcare and the life sciences spans medical [...]

By |2019-10-21T13:37:57-04:00October 21st, 2019|Press Releases|0 Comments

SmartPharm Therapeutics Announces Presentation at the 2019 BIO Investor Forum

SmartPharm Therapeutics Announces Presentation at the 2019 BIO Investor Forum CAMBRIDGE, Mass., Oct. 16, 2019 /PRNewswire/ -- SmartPharm Therapeutics, a preclinical-stage pharmaceutical company focused on developing next-generation, non-viral gene therapies for the treatment of rare diseases, today announced that José Trevejo, MD, PhD, Chief Executive Officer, will present at the 2019 BIO [...]

By |2019-11-01T14:23:12-04:00October 16th, 2019|Press Releases|0 Comments

SmartPharm is presenting at Chardan’s 3rd Annual Genetic Medicines Conference

We will be presenting on October 7th at 8:00 AM (ET) at Chardan's 3rd Annual Genetic Medicines Conference. Chardan's annual Genetic Medicines Conference is the largest sell-side conference focused exclusively on advancing the field of genetic medicines. Now in its 3rd year, this expanded one and half day conference brings together executives from more [...]

By |2019-10-04T12:54:48-04:00October 4th, 2019|Events|0 Comments

Oppenheimer Fall Summit Focused on Specialty Pharma and Rare Diseases

We will be at the Oppenheimer Fall Summit Focused on Specialty Pharma and Rare Disease CompaniesCompanies, New York, NY, September 23-24 The summit features one-on-one meetings with a select group companies focused on specialty pharma and orphan and rare disease. Investors will have the opportunity to meet with management teams to discuss in detail [...]

By |2019-10-03T18:42:21-04:00October 3rd, 2019|Events|0 Comments

SmartPharm Therapeutics Announces Presentation at the Chardan 3rd Annual Genetic Medicines Conference

SmartPharm Therapeutics Announces Presentation at the Chardan 3rd Annual Genetic Medicines Conference CAMBRIDGE, Mass. – September 30, 2019 – SmartPharm Therapeutics, a preclinical-stage pharmaceutical company focused on developing next-generation, non-viral gene therapies for the treatment of rare diseases, today announced that José Trevejo, MD, PhD, President and Chief Executive Officer, will present [...]

By |2019-09-30T10:32:50-04:00September 30th, 2019|Press Releases|0 Comments